FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204641435> ?p ?o ?g. }

• W3204641435 abstract "Mitochondrial diseases are difficult to diagnose and treat. Recent advances in genetic diagnostics and more effective treatment options can improve patient diagnosis and prognosis, but patients with mitochondrial disease typically experience delays in diagnosis and treatment. Here, we describe a unique collaborative practice model among physicians and scientists in Spain focused on identifying TK2 deficiency (TK2d), an ultra-rare mitochondrial DNA depletion and deletions syndrome.This collaboration spans research and clinical care, including laboratory scientists, adult and pediatric neuromuscular clinicians, geneticists, and pathologists, and has resulted in diagnosis and consolidation of care for patients with TK2d. The incidence of TK2d is not known; however, the first clinical cases of TK2d were reported in 2001, and only ~ 107 unique cases had been reported as of 2018. This unique collaboration in Spain has led to the diagnosis of more than 30 patients with genetically confirmed TK2d across different regions of the country. Research affiliate centers have led investigative treatment with nucleosides based on understanding of TK2d clinical manifestations and disease mechanisms, which resulted in successful treatment of a TK2d mouse model with nucleotide therapy in 2010. Only 1 year later, this collaboration enabled rapid adoption of treatment with pyrimidine nucleotides (and later, nucleosides) under compassionate use. Success in TK2d diagnosis and treatment in Spain is attributable to two important factors: Spain's fully public national healthcare system, and the designation in 2015 of major National Reference Centers for Neuromuscular Disorders (CSURs). CSUR networking and dissemination facilitated development of a collaborative care network for TK2d disease, wherein participants share information and protocols to request approval from the Ministry of Health to initiate nucleoside therapy. Data have recently been collected in a retrospective study conducted under a Good Clinical Practice-compliant protocol to support development of a new therapeutic approach for TK2d, a progressive disease with no approved therapies.The Spanish experience in diagnosis and treatment of TK2d is a model for the diagnosis and development of new treatments for very rare diseases within an existing healthcare system." @default.
• W3204641435 created "2021-10-11" @default.
• W3204641435 creator A5003199280 @default.
• W3204641435 creator A5003721649 @default.
• W3204641435 creator A5013496858 @default.
• W3204641435 creator A5035054317 @default.
• W3204641435 creator A5036543107 @default.
• W3204641435 creator A5050875837 @default.
• W3204641435 creator A5056424304 @default.
• W3204641435 creator A5061051970 @default.
• W3204641435 creator A5063144052 @default.
• W3204641435 creator A5065093217 @default.
• W3204641435 creator A5077279843 @default.
• W3204641435 creator A5089326307 @default.
• W3204641435 date "2021-10-02" @default.
• W3204641435 modified "2023-10-18" @default.
• W3204641435 title "Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency" @default.
• W3204641435 cites W1576093526 @default.
• W3204641435 cites W1967303222 @default.
• W3204641435 cites W1993997629 @default.
• W3204641435 cites W2004807060 @default.
• W3204641435 cites W2040148172 @default.
• W3204641435 cites W2044076490 @default.
• W3204641435 cites W2045671277 @default.
• W3204641435 cites W2051687965 @default.
• W3204641435 cites W2064492605 @default.
• W3204641435 cites W2109232765 @default.
• W3204641435 cites W2118426638 @default.
• W3204641435 cites W2144634403 @default.
• W3204641435 cites W2157010532 @default.
• W3204641435 cites W2598216227 @default.
• W3204641435 cites W2742011265 @default.
• W3204641435 cites W2790024787 @default.
• W3204641435 cites W2794794769 @default.
• W3204641435 cites W2801416513 @default.
• W3204641435 cites W2807744419 @default.
• W3204641435 cites W2901750318 @default.
• W3204641435 cites W2945506324 @default.
• W3204641435 cites W2947591702 @default.
• W3204641435 cites W2963153756 @default.
• W3204641435 cites W3003422849 @default.
• W3204641435 cites W3008546136 @default.
• W3204641435 cites W3036139492 @default.
• W3204641435 cites W3049401614 @default.
• W3204641435 cites W3106867058 @default.
• W3204641435 cites W3109095815 @default.
• W3204641435 cites W3165687536 @default.
• W3204641435 doi "https://doi.org/10.1186/s13023-021-02030-w" @default.
• W3204641435 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8487573" @default.
• W3204641435 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34600563" @default.
• W3204641435 hasPublicationYear "2021" @default.
• W3204641435 type Work @default.
• W3204641435 sameAs 3204641435 @default.
• W3204641435 citedByCount "2" @default.
• W3204641435 countsByYear W32046414352022 @default.
• W3204641435 countsByYear W32046414352023 @default.
• W3204641435 crossrefType "journal-article" @default.
• W3204641435 hasAuthorship W3204641435A5003199280 @default.
• W3204641435 hasAuthorship W3204641435A5003721649 @default.
• W3204641435 hasAuthorship W3204641435A5013496858 @default.
• W3204641435 hasAuthorship W3204641435A5035054317 @default.
• W3204641435 hasAuthorship W3204641435A5036543107 @default.
• W3204641435 hasAuthorship W3204641435A5050875837 @default.
• W3204641435 hasAuthorship W3204641435A5056424304 @default.
• W3204641435 hasAuthorship W3204641435A5061051970 @default.
• W3204641435 hasAuthorship W3204641435A5063144052 @default.
• W3204641435 hasAuthorship W3204641435A5065093217 @default.
• W3204641435 hasAuthorship W3204641435A5077279843 @default.
• W3204641435 hasAuthorship W3204641435A5089326307 @default.
• W3204641435 hasBestOaLocation W32046414351 @default.
• W3204641435 hasConcept C104317684 @default.
• W3204641435 hasConcept C142724271 @default.
• W3204641435 hasConcept C160735492 @default.
• W3204641435 hasConcept C162324750 @default.
• W3204641435 hasConcept C177713679 @default.
• W3204641435 hasConcept C187212893 @default.
• W3204641435 hasConcept C24586158 @default.
• W3204641435 hasConcept C2777614518 @default.
• W3204641435 hasConcept C2779134260 @default.
• W3204641435 hasConcept C2779701055 @default.
• W3204641435 hasConcept C50522688 @default.
• W3204641435 hasConcept C512399662 @default.
• W3204641435 hasConcept C54355233 @default.
• W3204641435 hasConcept C60644358 @default.
• W3204641435 hasConcept C71924100 @default.
• W3204641435 hasConcept C86803240 @default.
• W3204641435 hasConceptScore W3204641435C104317684 @default.
• W3204641435 hasConceptScore W3204641435C142724271 @default.
• W3204641435 hasConceptScore W3204641435C160735492 @default.
• W3204641435 hasConceptScore W3204641435C162324750 @default.
• W3204641435 hasConceptScore W3204641435C177713679 @default.
• W3204641435 hasConceptScore W3204641435C187212893 @default.
• W3204641435 hasConceptScore W3204641435C24586158 @default.
• W3204641435 hasConceptScore W3204641435C2777614518 @default.
• W3204641435 hasConceptScore W3204641435C2779134260 @default.
• W3204641435 hasConceptScore W3204641435C2779701055 @default.
• W3204641435 hasConceptScore W3204641435C50522688 @default.
• W3204641435 hasConceptScore W3204641435C512399662 @default.
• W3204641435 hasConceptScore W3204641435C54355233 @default.
• W3204641435 hasConceptScore W3204641435C60644358 @default.

• next